SIMILAR PATTERNS OF AMINO ACIDS FOR 4DRI_A_RAPA201
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bhe | POLYGALACTURONASE (Pectobacteriumcarotovorum) |
PF00295(Glyco_hydro_28) | 5 | ASP A 224VAL A 267ILE A 242ILE A 204PHE A 247 | None | 1.16A | 4driA-1bheA:undetectable | 4driA-1bheA:17.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eom | ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 (Elizabethkingiameningoseptica) |
PF00704(Glyco_hydro_18) | 5 | ASP A 34VAL A 284ILE A 271TYR A 274ILE A 29 | None | 1.28A | 4driA-1eomA:undetectable | 4driA-1eomA:19.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | ASP A 142PHE A 153TRP A 162TYR A 185ILE A 194PHE A 202 | None | 1.10A | 4driA-1fd9A:17.5 | 4driA-1fd9A:25.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 9 | TYR A 131ASP A 142GLN A 157VAL A 158ILE A 159TRP A 162TYR A 185ILE A 194PHE A 202 | None | 0.86A | 4driA-1fd9A:17.5 | 4driA-1fd9A:25.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37ARG A 42ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | None | 0.87A | 4driA-1fkkA:19.8 | 4driA-1fkkA:40.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | None | 0.39A | 4driA-1fkkA:19.8 | 4driA-1fkkA:40.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 8 | TYR A 92ARG A 108VAL A 119ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.70A | 4driA-1jvwA:16.4 | 4driA-1jvwA:30.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 8 | TYR A 92ASP A 103ARG A 108ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.98A | 4driA-1jvwA:16.4 | 4driA-1jvwA:30.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 7 | TYR A 92PHE A 114ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.90A | 4driA-1jvwA:16.4 | 4driA-1jvwA:30.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 8 | TYR A 57PHE A 77GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.80A | 4driA-1kt1A:18.5 | 4driA-1kt1A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 7 | TYR A 57PHE A 77GLN A 85VAL A 86TRP A 90TYR A 113ILE A 122 | None | 1.41A | 4driA-1kt1A:18.5 | 4driA-1kt1A:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.56A | 4driA-1n1aA:22.5 | 4driA-1n1aA:61.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o0s | NAD-DEPENDENT MALICENZYME (Ascaris suum) |
PF00390(malic)PF03949(Malic_M) | 6 | ARG A 376GLN A 344VAL A 340ILE A 339ILE A 303PHE A 325 | None | 1.35A | 4driA-1o0sA:undetectable | 4driA-1o0sA:13.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o99 | 2,3-BISPHOSPHOGLYCERATE-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Geobacillusstearothermophilus) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 5 | ASP A 486ARG A 479VAL A 471ILE A 440ILE A 69 | None | 1.22A | 4driA-1o99A:undetectable | 4driA-1o99A:16.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.33A | 4driA-1pbkA:18.8 | 4driA-1pbkA:38.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 146ASP A 157ARG A 162ILE A 174TRP A 177TYR A 200ILE A 208PHE A 216 | None | 0.79A | 4driA-1q6hA:16.9 | 4driA-1q6hA:30.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 146ASP A 157VAL A 173ILE A 174TRP A 177TYR A 200ILE A 208PHE A 216 | None | 0.56A | 4driA-1q6hA:16.9 | 4driA-1q6hA:30.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 9 | TYR A 40ASP A 51ARG A 56VAL A 69ILE A 70TRP A 73TYR A 96ILE A 105PHE A 113 | None | 0.81A | 4driA-1r9hA:23.6 | 4driA-1r9hA:46.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 9 | TYR A 40ASP A 51PHE A 60VAL A 69ILE A 70TRP A 73TYR A 96ILE A 105PHE A 113 | None | 0.53A | 4driA-1r9hA:23.6 | 4driA-1r9hA:46.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ry2 | ACETYL-COENZYME ASYNTHETASE 1 (Saccharomycescerevisiae) |
PF00501(AMP-binding)PF13193(AMP-binding_C)PF16177(ACAS_N) | 5 | PHE A 349VAL A 466ILE A 465TYR A 454ILE A 458 | None | 1.08A | 4driA-1ry2A:undetectable | 4driA-1ry2A:10.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 7 | TYR A 37ARG A 53VAL A 66ILE A 67TRP A 70TYR A 99PHE A 121 | None | 0.82A | 4driA-1u79A:19.0 | 4driA-1u79A:35.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 8 | TYR A 37ASP A 48VAL A 66ILE A 67TRP A 70TYR A 99ILE A 113PHE A 121 | None | 0.42A | 4driA-1u79A:19.0 | 4driA-1u79A:35.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37ARG A 42ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | FK5 A 108 ( 4.0A)FK5 A 108 ( 3.3A)FK5 A 108 (-3.7A)FK5 A 108 ( 3.7A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A)NoneNone | 0.69A | 4driA-1yatA:21.0 | 4driA-1yatA:38.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 10 | TYR A 26ASP A 37PHE A 46GLN A 54VAL A 55ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | FK5 A 108 ( 4.0A)FK5 A 108 ( 3.3A)FK5 A 108 ( 4.0A)NoneFK5 A 108 ( 3.4A)FK5 A 108 ( 3.7A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A)NoneNone | 0.41A | 4driA-1yatA:21.0 | 4driA-1yatA:38.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gh4 | PUTATIVE GLYCOSYLHYDROLASE YTER (Bacillussubtilis) |
PF07470(Glyco_hydro_88) | 5 | TYR A 285ASP A 224ARG A 52TYR A 295ILE A 226 | None | 1.22A | 4driA-2gh4A:undetectable | 4driA-2gh4A:16.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 6 | TYR A 27PHE A 47VAL A 56ILE A 57TRP A 60ILE A 92 | None | 1.01A | 4driA-2lpvA:16.6 | 4driA-2lpvA:38.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67GLN A 84VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | PEG A 201 (-4.4A)NoneNonePEG A 201 (-3.6A)PEG A 201 (-3.8A)PEG A 201 (-3.7A)NoneNoneNone | 0.76A | 4driA-2pbcA:15.5 | 4driA-2pbcA:38.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | PEG A 201 (-4.4A)NonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)PEG A 201 (-3.8A)PEG A 201 (-3.7A)NoneNoneNone | 0.75A | 4driA-2pbcA:15.5 | 4driA-2pbcA:38.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.79A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.80A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.70A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.95A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 8 | TYR A 44ASP A 56ARG A 61ILE A 75TRP A 78TYR A 101ILE A 110PHE A 118 | FK5 A 501 (-4.1A)FK5 A 501 (-3.4A)FK5 A 501 (-3.9A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A)NoneFK5 A 501 (-4.8A) | 0.68A | 4driA-2vn1A:21.9 | 4driA-2vn1A:46.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 9 | TYR A 44ASP A 56PHE A 65VAL A 74ILE A 75TRP A 78TYR A 101ILE A 110PHE A 118 | FK5 A 501 (-4.1A)FK5 A 501 (-3.4A)FK5 A 501 (-4.1A)FK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A)NoneFK5 A 501 (-4.8A) | 0.35A | 4driA-2vn1A:21.9 | 4driA-2vn1A:46.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x7q | POSSIBLE THIAMINEBIOSYNTHESIS ENZYME (Candidaalbicans) |
PF09084(NMT1) | 5 | TYR A 26GLN A 218TYR A 81ILE A 58PHE A 209 | None | 1.23A | 4driA-2x7qA:undetectable | 4driA-2x7qA:19.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 9 | TYR A 33ASP A 44ARG A 49VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.82A | 4driA-2y78A:19.0 | 4driA-2y78A:42.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 9 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.64A | 4driA-2y78A:19.0 | 4driA-2y78A:42.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zy2 | L-ASPARTATE4-CARBOXYLYASE (Pseudomonas sp.ATCC 19121) |
PF00155(Aminotran_1_2) | 5 | ASP A 286PHE A 204ILE A 210ILE A 181PHE A 250 | PLP A 900 (-3.2A)PLP A 900 (-4.2A)NoneNoneNone | 1.03A | 4driA-2zy2A:undetectable | 4driA-2zy2A:14.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b7x | FK506-BINDINGPROTEIN 6 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 61ASP A 73TYR A 118ILE A 127PHE A 135 | None | 0.93A | 4driA-3b7xA:17.7 | 4driA-3b7xA:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 10 | TYR A 57ASP A 68PHE A 77GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.68A | 4driA-3o5dA:23.2 | 4driA-3o5dA:99.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68PHE A 77GLN A 85VAL A 86ILE A 87TYR A 113ILE A 122PHE A 130 | None | 0.66A | 4driA-3o5eA:23.9 | 4driA-3o5eA:99.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 77GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.66A | 4driA-3o5eA:23.9 | 4driA-3o5eA:99.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3owu | STEROIDDELTA-ISOMERASE (Pseudomonasputida) |
PF12680(SnoaL_2) | 5 | ASP A 103GLN A 59ILE A 53TYR A 32ILE A 113 | EQU A 200 (-2.9A)NoneNoneNoneNone | 1.26A | 4driA-3owuA:undetectable | 4driA-3owuA:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 8 | TYR A 43ARG A 60VAL A 73ILE A 74TRP A 77TYR A 100ILE A 109PHE A 117 | None | 0.65A | 4driA-3pa7A:21.4 | 4driA-3pa7A:44.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 8 | TYR A 43ASP A 55ARG A 60VAL A 73ILE A 74TRP A 77ILE A 109PHE A 117 | None | 0.89A | 4driA-3pa7A:21.4 | 4driA-3pa7A:44.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 8 | TYR A 43ASP A 55PHE A 64VAL A 73ILE A 74TRP A 77ILE A 109PHE A 117 | None | 0.60A | 4driA-3pa7A:21.4 | 4driA-3pa7A:44.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 8 | TYR A 43PHE A 64VAL A 73ILE A 74TRP A 77TYR A 100ILE A 109PHE A 117 | None | 0.41A | 4driA-3pa7A:21.4 | 4driA-3pa7A:44.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sqw | ATP-DEPENDENT RNAHELICASE MSS116,MITOCHONDRIAL (Saccharomycescerevisiae) |
PF00270(DEAD)PF00271(Helicase_C) | 5 | ASP A 343VAL A 498ILE A 497TYR A 460ILE A 464 | None | 1.05A | 4driA-3sqwA:undetectable | 4driA-3sqwA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3um6 | BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE (Plasmodiumfalciparum) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | TYR A 569VAL A 210ILE A 224TYR A 226ILE A 200 | None | 1.25A | 4driA-3um6A:undetectable | 4driA-3um6A:14.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | ASP A 324VAL A 341ILE A 342TRP A 345TYR A 368ILE A 376PHE A 384 | None | 0.76A | 4driA-4bf8A:17.2 | 4driA-4bf8A:39.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313ASP A 324PHE A 332VAL A 341ILE A 342TRP A 345PHE A 384 | None | 0.78A | 4driA-4bf8A:17.2 | 4driA-4bf8A:39.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313ASP A 324VAL A 341ILE A 342TRP A 345TYR A 368PHE A 384 | None | 0.76A | 4driA-4bf8A:17.2 | 4driA-4bf8A:39.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4db4 | ATP-DEPENDENT RNAHELICASE MSS116,MITOCHONDRIAL (Saccharomycescerevisiae) |
PF00271(Helicase_C) | 5 | ASP A 343VAL A 498ILE A 497TYR A 460ILE A 464 | None | 1.09A | 4driA-4db4A:undetectable | 4driA-4db4A:21.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dip | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 52TRP A 88TYR A 111ILE A 119PHE A 127 | None | 0.55A | 4driA-4dipA:17.6 | 4driA-4dipA:31.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 8 | TYR A 33ASP A 44ARG A 49ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | FK5 A 201 ( 3.9A)FK5 A 201 (-3.5A)FK5 A 201 ( 3.7A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A)NoneFK5 A 201 (-4.8A) | 0.77A | 4driA-4dz3A:19.8 | 4driA-4dz3A:41.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 9 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | FK5 A 201 ( 3.9A)FK5 A 201 (-3.5A)FK5 A 201 (-4.1A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A)NoneFK5 A 201 (-4.8A) | 0.34A | 4driA-4dz3A:19.8 | 4driA-4dz3A:41.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h09 | HYPOTHETICAL LEUCINERICH REPEAT PROTEIN (Eubacteriumventriosum) |
PF13306(LRR_5) | 5 | PHE A 337VAL A 346ILE A 369ILE A 375PHE A 383 | None | 1.19A | 4driA-4h09A:undetectable | 4driA-4h09A:17.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 26ARG A 42PHE A 46VAL A 55ILE A 56TYR A 82ILE A 91PHE A 99 | None | 0.83A | 4driA-4iqcA:19.6 | 4driA-4iqcA:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37ARG A 42PHE A 46ILE A 56TYR A 82ILE A 91PHE A 99 | None | 0.97A | 4driA-4iqcA:19.6 | 4driA-4iqcA:37.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) |
PF00905(Transpeptidase) | 5 | PHE A 81GLN A 144VAL A 147ILE A 150PHE A 180 | None | 1.15A | 4driA-4k0xA:undetectable | 4driA-4k0xA:22.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.65A | 4driA-4lawA:23.5 | 4driA-4lawA:59.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.78A | 4driA-4lawA:23.5 | 4driA-4lawA:59.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4msp | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C)PF13499(EF-hand_7) | 5 | TYR A 33TRP A 69TYR A 92ILE A 100PHE A 108 | None | 0.50A | 4driA-4mspA:17.7 | 4driA-4mspA:27.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67GLN A 84VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | FK5 A 201 (-4.1A)FK5 A 201 (-3.4A)NoneFK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A)NoneFK5 A 201 (-4.9A) | 0.60A | 4driA-4nnrA:16.2 | 4driA-4nnrA:43.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | FK5 A 201 (-4.1A)FK5 A 201 (-3.4A)FK5 A 201 (-4.0A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A)NoneFK5 A 201 (-4.9A) | 0.36A | 4driA-4nnrA:16.2 | 4driA-4nnrA:43.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odm | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD (Thermusthermophilus) |
PF00254(FKBP_C) | 5 | TYR A 13ASP A 23ILE A 37TYR A 63PHE A 128 | None | 0.50A | 4driA-4odmA:11.6 | 4driA-4odmA:19.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA (Homo sapiens;Thermusthermophilus) |
PF00254(FKBP_C) | 6 | TYR A 13ASP A 23ILE A 37TYR A 63ILE A 72PHE A 80 | FK5 A 201 ( 3.6A)FK5 A 201 (-3.6A)FK5 A 201 (-3.9A)FK5 A 201 (-4.4A)NoneFK5 A 201 ( 4.8A) | 0.40A | 4driA-4odrA:13.1 | 4driA-4odrA:22.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ARG A 73GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.81A | 4driA-4r0xA:23.9 | 4driA-4r0xA:85.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68ARG A 73GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.86A | 4driA-4r0xA:23.9 | 4driA-4r0xA:85.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68PHE A 77GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.69A | 4driA-4r0xA:23.9 | 4driA-4r0xA:85.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 77GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.59A | 4driA-4r0xA:23.9 | 4driA-4r0xA:85.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z7l | CAS6B (Methanococcusmaripaludis) |
PF17262(DUF5328) | 5 | TYR A 31ILE A 63TYR A 10ILE A 94PHE A 27 | None | 1.25A | 4driA-4z7lA:undetectable | 4driA-4z7lA:19.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2o | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Francisellatularensis) |
no annotation | 5 | PHE A1576VAL A1561ILE A1547TYR A1549ILE A1611 | None | 1.25A | 4driA-5b2oA:undetectable | 4driA-5b2oA:7.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b86 | TUMOR NECROSISFACTOR ALPHA-INDUCEDPROTEIN 2 (Mus musculus) |
PF06046(Sec6) | 5 | TYR A 600VAL A 522ILE A 526ILE A 611PHE A 644 | None | 1.26A | 4driA-5b86A:undetectable | 4driA-5b86A:13.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 9 | TYR C 36ASP C 56ARG C 61VAL C 73ILE C 74TRP C 77TYR C 100ILE C 109PHE C 117 | FK5 C 201 (-4.1A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)NoneFK5 C 201 (-4.7A) | 0.57A | 4driA-5b8iC:18.6 | 4driA-5b8iC:33.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 9 | TYR C 36ASP C 56PHE C 64VAL C 73ILE C 74TRP C 77TYR C 100ILE C 109PHE C 117 | FK5 C 201 (-4.1A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)NoneFK5 C 201 (-4.7A) | 0.40A | 4driA-5b8iC:18.6 | 4driA-5b8iC:33.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37ARG A 42PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 146 | None | 0.79A | 4driA-5i7pA:18.1 | 4driA-5i7pA:29.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37ARG A 42VAL A 55ILE A 56TRP A 59TYR A 82PHE A 147 | None | 0.76A | 4driA-5i7qA:18.3 | 4driA-5i7qA:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 147 | None | 0.46A | 4driA-5i7qA:18.3 | 4driA-5i7qA:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 9 | TYR A 30ASP A 41ARG A 46PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 102 | None | 1.34A | 4driA-5i98A:18.1 | 4driA-5i98A:39.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 10 | TYR A 30ASP A 41ARG A 46PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 106PHE A 114 | None | 0.66A | 4driA-5i98A:18.1 | 4driA-5i98A:39.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 9 | TYR A 30ASP A 41PHE A 50GLN A 58VAL A 59ILE A 60TRP A 63TYR A 97ILE A 102 | None | 1.41A | 4driA-5i98A:18.1 | 4driA-5i98A:39.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 10 | TYR A 30ASP A 41PHE A 50GLN A 58VAL A 59ILE A 60TRP A 63TYR A 97ILE A 106PHE A 114 | None | 0.58A | 4driA-5i98A:18.1 | 4driA-5i98A:39.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 7 | TYR A 27ASP A 38ARG A 43ILE A 57TYR A 83ILE A 92PHE A 100 | None | 1.05A | 4driA-5j6eA:19.6 | 4driA-5j6eA:40.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 9 | TYR A 27ASP A 38PHE A 47VAL A 56ILE A 57TRP A 60TYR A 83ILE A 92PHE A 100 | None | 0.54A | 4driA-5j6eA:19.6 | 4driA-5j6eA:40.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jcv | LMO2181 PROTEIN (Listeriamonocytogenes) |
PF04203(Sortase) | 5 | ASP A 125VAL A 75ILE A 89TYR A 161ILE A 221 | None | 1.03A | 4driA-5jcvA:undetectable | 4driA-5jcvA:21.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m8h | ATPPHOSPHORIBOSYLTRANSFERASE (Psychrobacterarcticus) |
PF01634(HisG) | 5 | TYR E 145ASP E 193GLN E 152VAL E 153ILE E 134 | None | 1.22A | 4driA-5m8hE:undetectable | 4driA-5m8hE:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m99 | ALPHA-AMYLASE (Thermotogapetrophila) |
PF00128(Alpha-amylase) | 5 | ASP B 213VAL B 195ILE B 198TYR B 88ILE B 85 | EDO B 616 ( 2.8A)NoneNoneNoneNone | 1.22A | 4driA-5m99B:undetectable | 4driA-5m99B:15.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5msz | THERMOBIA DOMESTICADOMESTICA AA15 (Thermobiadomestica) |
no annotation | 5 | ASP A 84VAL A 72ILE A 190TYR A 75ILE A 81 | None | 1.06A | 4driA-5mszA:undetectable | 4driA-5mszA:19.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5odr | HETERODISULFIDEREDUCTASE, SUBUNIT B (Methanothermococcusthermolithotrophicus) |
PF02754(CCG) | 5 | ASP B 35ARG B 23VAL B 75ILE B 74ILE B 66 | None | 1.14A | 4driA-5odrB:undetectable | 4driA-5odrB:22.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 6 | TYR A 33ASP A 44ARG A 49TYR A 89ILE A 98PHE A 106 | 8ZV A 201 (-3.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-4.6A)8ZV A 201 ( 4.8A)8ZV A 201 (-4.6A) | 0.90A | 4driA-5v8tA:19.9 | 4driA-5v8tA:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 9 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | 8ZV A 201 (-3.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-4.0A)8ZV A 201 (-3.3A)8ZV A 201 (-4.6A)8ZV A 201 ( 4.8A)8ZV A 201 (-4.6A) | 0.26A | 4driA-5v8tA:19.9 | 4driA-5v8tA:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wpi | HSVA (Erwiniaamylovora) |
no annotation | 5 | TYR A 296PHE A 58VAL A 40ILE A 38PHE A 345 | TYR A 296 ( 1.3A)PHE A 58 ( 1.3A)VAL A 40 ( 0.5A)ILE A 38 ( 0.7A)PHE A 345 ( 1.3A) | 1.29A | 4driA-5wpiA:undetectable | 4driA-5wpiA:17.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7u | TREHALOSE SYNTHASE (Thermobaculumterrenum) |
no annotation | 5 | ASP A 202GLN A 181ILE A 187TYR A 70ILE A 67 | TRS A 600 (-2.8A)NoneNoneNoneNone | 1.06A | 4driA-5x7uA:undetectable | 4driA-5x7uA:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 8 | TYR A 147ASP A 158PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.04A | 4driA-5xb0A:16.6 | 4driA-5xb0A:30.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 8 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.66A | 4driA-5xb0A:16.6 | 4driA-5xb0A:30.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z0y | SERINEHYDROXYMETHYLTRANSFERASE (Komagataellaphaffii) |
no annotation | 5 | TYR A 339ASP A 418VAL A 393ILE A 395PHE A 334 | None | 1.25A | 4driA-5z0yA:undetectable | 4driA-5z0yA:15.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 8 | TYR A 38ASP A 49ARG A 54ILE A 68TRP A 71TYR A 94ILE A 103PHE A 111 | None | 0.84A | 4driA-6b4pA:21.3 | 4driA-6b4pA:45.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 8 | TYR A 38ASP A 49PHE A 58VAL A 67ILE A 68TRP A 71TYR A 94ILE A 99 | None | 1.48A | 4driA-6b4pA:21.3 | 4driA-6b4pA:45.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 9 | TYR A 38ASP A 49PHE A 58VAL A 67ILE A 68TRP A 71TYR A 94ILE A 103PHE A 111 | None | 0.61A | 4driA-6b4pA:21.3 | 4driA-6b4pA:45.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1clw | TAILSPIKE PROTEIN (Salmonellavirus P22) |
PF09251(PhageP22-tail) | 5 | LEU A 647SER A 646TRP A 640ASP A 623TYR A 639 | None | 1.41A | 4driB-1clwA:undetectable | 4driB-1clwA:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dy2 | COLLAGEN ALPHA1(XV)CHAIN (Mus musculus) |
PF06482(Endostatin) | 5 | LEU A 122SER A 124ARG A 201THR A 212ASP A 98 | None | 1.47A | 4driB-1dy2A:undetectable | 4driB-1dy2A:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ks5 | ENDOGLUCANASE A (Aspergillusniger) |
PF01670(Glyco_hydro_12) | 5 | LEU A 121SER A 165ARG A 123THR A 138TRP A 144 | None | 1.32A | 4driB-1ks5A:undetectable | 4driB-1ks5A:15.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mty | METHANEMONOOXYGENASEHYDROXYLASE (Methylococcuscapsulatus) |
PF02964(MeMO_Hyd_G) | 5 | LEU G 60THR G 11TRP G 15ASP G 52TYR G 53 | None | 1.49A | 4driB-1mtyG:1.5 | 4driB-1mtyG:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n7g | GDP-D-MANNOSE-4,6-DEHYDRATASE (Arabidopsisthaliana) |
PF16363(GDP_Man_Dehyd) | 5 | LEU A 212SER A 163ARG A 253PHE A 166ASP A 276 | NDP A 701 (-4.9A)GDR A 801 (-3.5A)GDR A 801 (-3.4A)NoneNone | 1.46A | 4driB-1n7gA:0.0 | 4driB-1n7gA:13.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t6r | PUTATIVE ANTI-SIGMAFACTOR ANTAGONISTTM1442 (Thermotogamaritima) |
PF01740(STAS) | 5 | LEU A 65ARG A 36PHE A 38ASP A 50PHE A 101 | None | 1.47A | 4driB-1t6rA:undetectable | 4driB-1t6rA:20.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xt0 | GUANINE NUCLEOTIDEEXCHANGE PROTEIN (Legionellapneumophila) |
PF01369(Sec7) | 5 | LEU B 183GLU B 182SER B 185THR B 158ASP B 160 | None | 1.47A | 4driB-1xt0B:1.2 | 4driB-1xt0B:18.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2npu | FKBP12-RAPAMYCINCOMPLEX-ASSOCIATEDPROTEIN (Homo sapiens) |
PF08771(FRB_dom) | 6 | LEU A2031GLU A2032SER A2035THR A2098TRP A2101ASP A2102 | None | 0.91A | 4driB-2npuA:13.5 | 4driB-2npuA:91.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o42 | M11L PROTEIN (Myxoma virus) |
PF11099(M11L) | 5 | LEU A 5SER A 3THR A 22ASP A 11TYR A 10 | None | 1.26A | 4driB-2o42A:0.0 | 4driB-2o42A:18.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b7y | E3 UBIQUITIN-PROTEINLIGASE NEDD4 (Homo sapiens) |
PF00168(C2) | 5 | LEU A 244ARG A 124THR A 163TRP A 172PHE A 189 | None | 1.35A | 4driB-3b7yA:undetectable | 4driB-3b7yA:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hhr | HUMAN GROWTH HORMONERECEPTOR (HGHBP) (Homo sapiens) |
PF00041(fn3)PF09067(EpoR_lig-bind) | 5 | LEU B 66GLU B 82THR B 51TRP B 50PHE B 67 | None | 1.42A | 4driB-3hhrB:undetectable | 4driB-3hhrB:19.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o44 | HEMOLYSIN (Vibrio cholerae) |
PF07968(Leukocidin)PF12563(Hemolysin_N)PF16458(Beta-prism_lec) | 5 | LEU A 188GLU A 189THR A 396TRP A 450ASP A 451 | None | 1.18A | 4driB-3o44A:undetectable | 4driB-3o44A:9.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u0k | RCAMP (Entacmaeaquadricolor) |
PF01353(GFP)PF13499(EF-hand_7) | 5 | LEU A 363ARG A 368THR A 320ASP A 314PHE A 306 | NoneNoneNone CA A 447 (-3.7A)None | 1.33A | 4driB-3u0kA:0.0 | 4driB-3u0kA:13.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4chj | IMC SUB-COMPARTMENTPROTEIN ISP3 (Toxoplasmagondii) |
no annotation | 5 | LEU A 144GLU A 147THR A 135ASP A 136PHE A 143 | None | 1.31A | 4driB-4chjA:undetectable | 4driB-4chjA:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fay | MICROCOMPARTMENTSPROTEIN (Lactobacillusreuteri) |
PF00936(BMC) | 5 | LEU A 112ARG A 117PHE A 119THR A 55ASP A 22 | NoneNoneNoneGOL A 304 (-4.6A)None | 0.82A | 4driB-4fayA:1.5 | 4driB-4fayA:12.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4px9 | ATP-DEPENDENT RNAHELICASE DDX3X (Homo sapiens) |
PF00270(DEAD) | 5 | LEU A 403THR A 378ASP A 219TYR A 400PHE A 402 | None | 1.31A | 4driB-4px9A:0.0 | 4driB-4px9A:15.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y5z | IMMUNOGLOBULING-BINDING PROTEINA,COAT PROTEIN (Sesbania mosaicvirus;Staphylococcusaureus) |
no annotation | 5 | LEU A 98GLU A 97SER A 96THR A 150ASP A 149 | None | 1.46A | 4driB-4y5zA:undetectable | 4driB-4y5zA:16.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5coc | IMMUNOGLOBULING-BINDING PROTEINA,CALMODULIN (Homo sapiens;Staphylococcusaureus) |
PF02216(B)PF13499(EF-hand_7) | 5 | LEU A1070ARG A1075THR A1027ASP A1021PHE A1013 | NoneNoneNone CA A1102 (-3.4A)None | 1.44A | 4driB-5cocA:0.3 | 4driB-5cocA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e7j | ATP-DEPENDENT RNAHELICASE DDX3X (Homo sapiens) |
PF00270(DEAD)PF00271(Helicase_C) | 5 | LEU A 403THR A 378ASP A 219TYR A 400PHE A 402 | None | 1.29A | 4driB-5e7jA:undetectable | 4driB-5e7jA:13.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h64 | SERINE/THREONINE-PROTEIN KINASE MTOR (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08771(FRB_dom)PF11865(DUF3385) | 5 | LEU A2031GLU A2032SER A2035PHE A2039TRP A2101 | None | 0.93A | 4driB-5h64A:14.4 | 4driB-5h64A:7.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h64 | SERINE/THREONINE-PROTEIN KINASE MTOR (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08771(FRB_dom)PF11865(DUF3385) | 6 | LEU A2031GLU A2032SER A2035THR A2098TRP A2101PHE A2108 | None | 0.90A | 4driB-5h64A:14.4 | 4driB-5h64A:7.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jp2 | F-BAR DOMAIN ONLYPROTEIN 1 (Danio rerio) |
PF10291(muHD) | 5 | ARG A 937THR A 914ASP A 912TYR A 999PHE A 947 | None | 1.43A | 4driB-5jp2A:undetectable | 4driB-5jp2A:17.14 |